Exhibit 99.1 (b) 2

TechRx Incorporated

Consolidated Balance Sheets

May 31, 2002 and June 30, 2001

	2002			2001
	(Dollars in Thousands)
Assets
Current assets:
Cash	$	7,349		$	11,513
Accounts receivable:
(including amounts due from NDCHealth)—net of an allowance for doubtful accounts of $741 in 2002 and $832 in 2001		7,687			6,587
Prepaid expenses and other		1,444			1,239
Total current assets		16,480			19,339
Property and equipment:
Furniture		984			1,518
Office equipment		722			790
Leasehold improvements		641			628
Computer software and hardware		5,292			3,206
Construction in progress		571			—
		8,210			6,142
Less accumulated depreciation/amortization		(2,087	)		(2,239	)
Total fixed assets		6,123			3,903
Other assets:
Software development costs		6,401			—
Market development costs—net of accumulated amortization of $11,500 in 2002 and $6,000 in 2001		6,500			12,000
Goodwill—net of accumulated amortization of $3,172 in 2001		34,011			34,011
Other		151			109
Total assets	$	69,666		$	69,362

Exhibit 99.1 (b) 2

TechRx Incorporated

Consolidated Balance Sheets

May 31, 2002 and June 30, 2001

	2002			2001
	(Dollars in Thousands)
Liabilities and stockholders' equity
Current liabilities:
Accounts payable (including NDCHealth)	$	4,032		$	4,118
Accrued expenses		5,221			6,669
Accrued restructuring costs		2,059			1,938
Dividends payable to NDCHealth		646			—
Deferred revenue		8,216			8,767
Notes payable—chain customer		11,906			—
Current portion of long-term obligations (including NDCHealth)		7,118			7,665
Total current liabilities		39,198			29,157
Long-term obligations (including NDCHealth)		7,681			15,675
Total liabilities		46,879			44,832
Redeemable Convertible Series B preferred stock at $.001     par value, 3,000,000 shares authorized, issued     and outstanding in 2001		—			3,207
Stockholders’ equity:
Convertible Series A preferred stock at $.001 par value,     17,033,500 shares authorized, 6,973,500 shares issued and     outstanding, liquidation value of $3,070,000		3,070			3,070
Convertible Series C preferred stock at $.001 par value,     19,669,500 shares authorized, 9,203,540 shares issued     and outstanding in 2001		—			30,800
Common stock at $.001 par value; 90,000,000 shares     authorized; 32,098,671 and 15,123,205 shares issued     and outstanding, respectively		32			15
Additional paid-in capital		64,676			15,172
Warrants outstanding		1,928			3,295
Accumulated deficit		(46,693	)		(31,017	)
Cumulative translation adjustment		(49	)		26
Notes receivable from stockholders		(177	)		(38	)
Total stockholders’ equity		22,787			21,323
Total liabilities and stockholders’ equity	$	69,666		$	69,362

See accompanying notes.